Board of Directors

COMMITTED TO CHANGING THE FACE OF CANCER TREATMENT

 

The BioCanRx Board of Directors is responsible for ensuring financial accountability, scientific excellence, knowledge exchange and operational efficiency. The board approves policies and procedures consistent with the goals and mission of the network. It also determines the mandate, membership, authority and makeup of committees.

 

The Board provides leadership and direction to BioCanRx so that it remains on target with respect to its strategic plan and commitment to the NCE mandate.

 

MEMBERS OF THE BOARD:

newport_small
lorne2
jbell
hbryant
Ken Newport
Chair, Board of Directors
Dr. Lorne Babiuk
Vice-President, Research, University of Alberta
Dr.John Bell
Scientific Director, BioCanRx
Senior Scientist, The Ottawa Hospital
Professor, uOttawa
Dr. Heather Bryant
Vice-President Cancer Control, Canadian Partnership Against Cancer (CPAC)
edouville
darrell
bruce
kmacdonald
Dr. Elizabeth Douville
Founder and Managing Partner, AmorChem Venture Fund
Darrell Fox
Board Member and Senior Advisor, Terry Fox Research Institute
Bruce Galloway
Former Chair, Ovarian Cancer Canada
Kendra MacDonald
Partner, Deloitte
dstewart
avillanueva
dyoung
Dr. Duncan Stewart
CEO and Scientific Director, Ottawa Hospital Research Institute
Dr. Augusto Villanueva
Business Unit Head, Oncology, Merck Canada
Dr. Christine Williams
Deputy Director, Ontario Institute for Cancer Research (OICR)
Dr. David Young
Life Science Entrepreneur and Founder/CEO of Actium Research Inc.

 

EX-OFFICIO MEMBERS (NON-VOTING)

 

smichaud
Dr. Stéphanie Michaud
President and CEO, BioCanRx
Secretary, Board of Directors

 

OBSERVERS

 

Kimberly Douglas
Senior Program Manager, Networks of Centres of Excellence